Get started
Regencell Bioscience Holdings LimitedRR

Regencell Bioscience Holdings Limited

12.62USDR
−1.47−10.43%
At close at Mar 14, 23:59 GMT
USD
No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

RGC chart


Full chart

Key stats


Market capitalization
‪164.22 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.33 USD
Net income (FY)
‪−4.30 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪1.46 M‬
Beta (1Y)
−6.32

Employees


Employees (FY)
12
Change (1Y)
0
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−358.49 K‬ USD

About Regencell Bioscience Holdings Limited


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Yat-Gai Au
Website
regencellbioscience.com
Headquarters
Hong Kong
Founded
2014
FIGI
BBG00ZS40360
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Financials


Performance
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪‪−4.00 M‬‬
‪‪−3.00 M‬‬
‪‪−2.00 M‬‬
‪‪−1.00 M‬‬
‪0.00‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−2.80 M‬‬
‪‪−2.10 M‬‬
‪‪−1.40 M‬‬
‪‪−700.00 K‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−2.40 M‬‬
‪‪−1.80 M‬‬
‪‪−1.20 M‬‬
‪‪−600.00 K‬‬
‪0.00‬
Debt level and coverage
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪‪1.70 M‬‬
‪‪3.40 M‬‬
‪‪5.10 M‬‬
‪‪6.80 M‬‬
Debt
Free cash flow
Cash & equivalents

RGC news



No news here

Looks like there's nothing to report right now

Reload

Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RGC is 12.62 USD — it has decreased by −10.43% in the past 24 hours. Watch Regencell Bioscience Holdings Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Regencell Bioscience Holdings Limited stocks are traded under the ticker RGC.
RGC stock has risen by 209.31% compared to the previous week, the month change is a 231.23% rise, over the last year Regencell Bioscience Holdings Limited has showed a 139.92% increase.
RGC reached its all-time high on Aug 25, 2021 with the price of 59.00 USD, and its all-time low was 3.03 USD and was reached on Jul 22, 2024. View more price dynamics on RGC chart.
See other stocks reaching their highest and lowest prices.
RGC stock is 54.53% volatile and has beta coefficient of −6.32. Track Regencell Bioscience Holdings Limited stock price on the chart and check out the list of the most volatile stocks — is Regencell Bioscience Holdings Limited there?
Today Regencell Bioscience Holdings Limited has the market capitalization of ‪164.22 M‬, it has decreased by −0.52% over the last week.
Yes, you can track Regencell Bioscience Holdings Limited financials in yearly and quarterly reports right on TradingView.
RGC net income for the last half-year is ‪−2.24 M‬ USD, while the previous report showed ‪−2.07 M‬ USD of net income which accounts for −8.16% change. Track more Regencell Bioscience Holdings Limited financial stats to get the full picture.
No, RGC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 17, 2025, the company has 12.00 employees. See our rating of the largest employees — is Regencell Bioscience Holdings Limited on this list?
Like other stocks, RGC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Regencell Bioscience Holdings Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Regencell Bioscience Holdings Limited technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Regencell Bioscience Holdings Limited stock shows the buy signal. See more of Regencell Bioscience Holdings Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.